HPV diagnostic test study
Part of Infections clinical trials.
This study tests a new, quick diagnostic test for HPV (the virus that can cause cervical cancer). Researchers want to see if the test works well compared to regular tests. If you are due for an HPV test or a related procedure, this study may be a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cervix and are 21 or older.
- You are scheduled for an HPV test or a cervical procedure (like a LEEP, ECC, or biopsy) at MD Anderson or LBJ Hospital.
- You are willing and able to give permission to be in the study.
- You can speak and read English or Spanish.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if offering self-sampling for HPV testing makes it easier for people to get screened for cervical cancer. It is designed for patients at partner clinics in Texas who are due for screening.
This study tests a new community-based program to help women who are overdue for cervical cancer screening get easier access to testing. It’s designed for women in underserved areas of Texas who haven’t had a recent Pap or HPV test.
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
Hear when a new Human Papillomavirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.